Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
3.
J Dermatolog Treat ; 22(6): 359-65, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20964572

RESUMEN

BACKGROUND: Atopic dermatitis (AD) requires permanent skin care. OBJECTIVE: A cream containing 2% SO (sunflower oleodistillate), with peroxisome proliferator-activated receptor-alpha (PPAR-α) agonist properties, has been compared to a topical steroid (hydrocortisone butyro-propionate 1 mg/g). METHODS: An open, randomized study included two groups of 40 children (aged 3 months to 4 years). Group A applied the steroid and group B applied the 2% SO cream, twice a day. SCORAD (SCORing Atopic Dermatitis) was determined at D0, D7 and D21 and quality of life (QoL) at D0 and D21. RESULTS: SCORAD was similar at D0 (37.2 versus 36.9), D7 (18.9 versus 19.2) (-49% and -48%) and D21 (11 versus 9.4) (-70% and -75%) (p < 0.01 versus D0). The Infant Dermatitis Quality of Life and Dermatitis Family Impact Questionnaire improved similarly by 65%/67% in group A and 72%/75% in group B at D21 (p < 0.01 versus D0). CONCLUSION: A 2% SO cream has demonstrated therapeutic properties, using clinical scores and QoL, comparable to those of a topical steroid.


Asunto(s)
Dermatitis Atópica/diagnóstico , Dermatitis Atópica/tratamiento farmacológico , Hidrocortisona/uso terapéutico , PPAR alfa/antagonistas & inhibidores , PPAR alfa/uso terapéutico , Administración Tópica , Preescolar , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Emolientes , Femenino , Estudios de Seguimiento , Humanos , Lactante , Masculino , Calidad de Vida , Valores de Referencia , Factores de Riesgo , Índice de Severidad de la Enfermedad , Método Simple Ciego , Estadísticas no Paramétricas , Resultado del Tratamiento
4.
Exp Dermatol ; 19(6): 483-92, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20353516

RESUMEN

Early postnatal life is a period of active functional reorganization and cutaneous physiological adaptation to the extrauterine environment. Skin as the outermost organ of mammalians is endowed of multiple functions such as protection, secretion, absorption and thermoregulation. Birth stimulates the epidermal barrier maturation and the skin surface acidification especially in premature infants. In full-term infants the developed stratum corneum accomplishes competent barrier function, in contrast to prematures. Complete barrier maturation in preterm infants is fulfilled by 2-4 weeks of the postnatal life. However, in preterms with 23-25 weeks gestational age this process takes longer. Versatile regulatory mechanisms, namely skin surface acidity, calcium ion gradient and nuclear hormone receptors/ligands are interrelated in the complex postnatal newborn adaptation. The skin of newborns is adjusting quickly to the challenging environmental conditions of the postpartum. However, certain functions, for example, microcirculation, continue to develop even beyond the neonatal period, that is, up to the age of 14-17 weeks. Different environmental factors (for instance, dry and cold climate, diapers and cosmetic care procedures) influence the postnatal development of skin functional parameters such as stratum corneum hydration and the permeability barrier especially in premature infants. The aim of this article is to summarize the current knowledge on skin physiology in newborn and infants with a practical approach and to discuss the possible clinical consequences. This review offers the readership a critical and practical overview of skin physiology in newborns and infants. It emphasizes possible new research fields in neonatal and infantile skin physiology.


Asunto(s)
Adaptación Fisiológica/fisiología , Fenómenos Fisiológicos de la Piel , Piel/crecimiento & desarrollo , Animales , Humanos , Lactante , Recién Nacido , Piel/irrigación sanguínea , Piel/metabolismo
5.
Pediatr Dermatol ; 25(6): 606-12, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19067864

RESUMEN

Emollients are commonly used for their effectiveness on atopic skin, supported by a few clinical studies suggesting their potential role as corticosteroid sparing agents. We investigated the effect of a new natural emollient on corticosteroid sparing and quality of life of young atopic children and their family. Eighty-six patients (4-48 mos) with moderate atopic dermatitis were randomized by 20 pediatricians to five groups for 21 days: corticosteroids (from twice daily to one application every other day) combined or not with the studied cream (twice daily), and evaluated by SCORAD and specific quality of life questionnaires. At the end of the study, all five groups were statistically improved in terms of SCORAD and quality of life index. Thus, application of a topical corticosteroid every other day in addition to the studied cream was as effective as a once or twice daily application of the steroid alone. The studied cream had a significant impact on lichenification, excoriation and quality of life. A twice daily application of a new natural emollient provided a major corticosteroid sparing, improved lichenification and excoriation and improved the quality of life in children and their parents.


Asunto(s)
Corticoesteroides/administración & dosificación , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/fisiopatología , Emolientes/uso terapéutico , Aceites de Plantas/química , Calidad de Vida , Administración Tópica , Preescolar , Esquema de Medicación , Quimioterapia Combinada , Emolientes/química , Femenino , Humanos , Lactante , Masculino , Padres , Índice de Severidad de la Enfermedad , Aceite de Girasol , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...